MP29-16: First Prospective Clinical Assessment of The ILY Robotic Flexible Ureteroscopy Platform.
Saturday, May 4, 2024 9:30 AM to 11:30 AM · 2 hr. (US/Central)
302B
Abstract
Information
Full Abstract and Figures
Author Block
Elia Abou Chawareb*, Marwan Zein, Bachar El Baba, Noura Wahoud, Albert El Hajj, Beirut, Lebanon
Introduction
The ILY® robotic system is a novel robotic ureteroscopy manipulator characterized by a unique versatile design allowing its integration with a multitude of ureteroscopes and access sheaths, controlled by an ergonomic wireless joystick controller. We present the initial prospective clinical assessment of this robotic platform, focusing on its safety and effectiveness.
Methods
We prospectively collected data from January to August 2023 on patients who underwent elective robotic flexible ureteroscopy for renal stone treatment utilizing the ILY® robotic system at our institution. We compared patient demographics, stone characteristics, surgical durations, perioperative and postoperative complications, and follow-up parameters. Our goal was to assess the efficacy and safety of the ILY robotic ureteroscopy for treating kidney stones. Therefore, we analyzed complication rates, surgical durations, and the stone-free rate during follow-up.
Results
Our cohort consisted of 29 patients and 31 kidney units, presenting with 45 stones with an average volume of 1313.37 mm3. The average operation time was 83.77 minutes, accompanied by 4.05 minutes for robot draping, 4.21 minutes for robot docking, 51.46 minutes of console operation, and a lasing time of 44.24 minutes. Postoperative stay for all patients was 1 day, while complications were observed in 9.68% of cases. To note, all complications were classified as CVD class 1 due to DJ stent discomfort. The stone-free rate achieved was 93.55%, and none of the patients' required reoperation for the treated stone.
Conclusions
In this first prospective clinical experience of the ILY robotic FURS, we were able to demonstrate the ILY® robotic system’s efficacy and safety. However, further investigations are still required to investigate the ILY® robotic system's clinical practicality and advantages, including direct comparative analyses with manual flexible ureteroscopy techniques.
Source Of Funding
None
Author Block
Elia Abou Chawareb*, Marwan Zein, Bachar El Baba, Noura Wahoud, Albert El Hajj, Beirut, Lebanon
Introduction
The ILY® robotic system is a novel robotic ureteroscopy manipulator characterized by a unique versatile design allowing its integration with a multitude of ureteroscopes and access sheaths, controlled by an ergonomic wireless joystick controller. We present the initial prospective clinical assessment of this robotic platform, focusing on its safety and effectiveness.
Methods
We prospectively collected data from January to August 2023 on patients who underwent elective robotic flexible ureteroscopy for renal stone treatment utilizing the ILY® robotic system at our institution. We compared patient demographics, stone characteristics, surgical durations, perioperative and postoperative complications, and follow-up parameters. Our goal was to assess the efficacy and safety of the ILY robotic ureteroscopy for treating kidney stones. Therefore, we analyzed complication rates, surgical durations, and the stone-free rate during follow-up.
Results
Our cohort consisted of 29 patients and 31 kidney units, presenting with 45 stones with an average volume of 1313.37 mm3. The average operation time was 83.77 minutes, accompanied by 4.05 minutes for robot draping, 4.21 minutes for robot docking, 51.46 minutes of console operation, and a lasing time of 44.24 minutes. Postoperative stay for all patients was 1 day, while complications were observed in 9.68% of cases. To note, all complications were classified as CVD class 1 due to DJ stent discomfort. The stone-free rate achieved was 93.55%, and none of the patients' required reoperation for the treated stone.
Conclusions
In this first prospective clinical experience of the ILY robotic FURS, we were able to demonstrate the ILY® robotic system’s efficacy and safety. However, further investigations are still required to investigate the ILY® robotic system's clinical practicality and advantages, including direct comparative analyses with manual flexible ureteroscopy techniques.
Source Of Funding
None